Clinical Trial Update: Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating the combination of chemotherapy, amifostine, and radiation therapy in patients with non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Amifostine (amifostine)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Drug/Agent Toxicity by Tissue/Organ, Lung Cancer | Phase 2 | Status: COMPLETED